A recent study examined the long-term effects of medical and surgical treatments of T2DM on patient reported outcomes.
Study shows that formerly obese men with T2D can enjoy the benefits of higher testosterone levels for at least five years following bariatric surgery.
Ancillary study to STAMPEDE study measures the five-year outcomes of bariatric surgery versus guideline-recommended intensive medical therapy on bone turnover in obese patients.
Cleveland Clinic researchers are heading the first long-term study to evaluate the effectiveness of bariatric surgery compared with medical therapy for treating Type 2 diabetes.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
From heart benefits of diabetes drugs to leadless pacing to expanding populations for TAVR, 2016 was a dynamic year in cardiovascular care. Cleveland Clinic experts reflect on a dozen key developments.
Are medication and lifestyle changes failing to get type 2 diabetes in control? New clinical guidelines make bariatric surgery a standard treatment option for diabetics with mild obesity.
At AACE Cleveland Clinic researchers presented results of a study comparing pre- and post-operative insulin regimens and dosages in patients with T2D who had undergone gastric bypass.
Cleveland Clinic study finds gastric bypass surgery is a viable option for obese patients and should be considered early in the course of type 2 diabetes treatment.